GS - Quantamentals - The Quality Factor
GS - Quantamentals - The Quality Factor
Quantamentals:
The Quality Factor
Equity Research
all metrics since Inception (Sept 2006-March 2017) Valuation: an average of P/E, P/B, dividend yield, EV/FCF,
EV/EBITDA and EV/DACF (Financials: only P/E, P/B and
2.0 dividend yield are included).
1.6
Information Ratio
Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result, investors
should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors
should consider this report as only a single factor in making their investment decision. For Reg AC certification and other
important disclosures, see the Disclosure Appendix, or go to www.gs.com/research/hedge.html. Analysts employed by
non-US affiliates are not registered/qualified as research analysts with FINRA in the U.S.
Performance (Total Return) Shading denotes best and worst performing fundamental factor
Integrated (High vs Low) 8% 12% 4% 9% 3% 4% 4% 0% 11% 8% 1%
Valuation (Cheap vs Rich) 6% -7% 4% 21% 1% 0% 3% 6% 14% 3% 9%
Growth (High vs Low) 2% 9% -15% 19% 8% -4% 2% 0% -6% 1% 1%
Returns (High vs Low) 1% 17% 10% -22% -7% 5% -3% -3% 8% 16% -14%
Balance Sheet (Strong vs Weak) 1% 12% 13% -20% 7% 4% -5% -3% 2% 12% -8%
Size (Large vs Small) -4% 13% 4% -33% -15% 0% -7% -8% 15% 14% -21%
Volatility (Low vs High) -5% 0% 20% -50% -16% 8% -7% -7% 10% 18% -18%
Volatility (Standard Deviation) Shading denotes fundamental factor with the lowest/highest vol in any given year
Integrated (High vs Low) 5% 4% 9% 7% 4% 4% 5% 3% 4% 4% 5%
Valuation (Cheap vs Rich) 6% 6% 11% 8% 5% 6% 6% 4% 6% 5% 5%
Growth (High vs Low) 6% 5% 8% 8% 5% 5% 6% 4% 6% 4% 6%
Returns (High vs Low) 9% 5% 14% 15% 6% 7% 6% 4% 5% 7% 11%
Balance Sheet (Strong vs Weak) 7% 4% 13% 12% 4% 4% 4% 4% 4% 6% 9%
Size (Large vs Small) 11% 7% 15% 17% 9% 11% 7% 6% 8% 10% 16%
Volatility (Low vs High) 16% 7% 27% 27% 13% 16% 10% 7% 10% 11% 20%
Note: (1) * since inception has been annualized and is through March 14, 2017, (2) All performance figures are based on our proprietary Investment Profile framework, which ranks and
normalizes our analyst estimates into specific style buckets. Companies are grouped into highest quintile (Q1 or top 20%) as Buys and lowest quintiles (Q5 or bottom 20%) as Sells in each
coverage sector and performance is equal-weighted. The performance of the combined market neutral strategies will not necessarily equal the difference between their two component tails
because of the effects of rebalancing. The combined strategies are reweighted on a weekly basis to maintain a market-neutral position. (3) We calculate perf and std deviation on an annualized
basis, with the latter based on daily total returns over a trailing 12-m period, (4) In the case of our market-neutral factor model, the short leg acts as the benchmark when calculating the IR.
From a sector perceptive, Industrials, Health Care and Financials detracted from
the headline performance. See Exhibit 4. We note that in years when Integrated
fares well, it tends to be consistent across the majority of sectors (78% in 2011,
2012 and 2014; 56% in 2015). See Exhibit 5.
Exhibit 2: Performance has been most correlated w/ Returns Exhibit 3: and there is significant overlap between names
3m rolling correlation based on daily price changes % of names also in Q1/Q5 Growth, Returns, Value
100% 65%
80% 60%
Factor Constituent Overlap (%)
60% 55%
50%
3 month Correlation
40%
45%
20%
40%
0%
35%
-20%
30%
-40%
Integrated Correl with Growth 25%
-60% Integrated Correl with Returns
Integrated Correl with Valuation
-80% Integrated & Growth (Q1) Integrated & Growth (Q5)
Integrated & Valuation (Q1) Integrated & Valuation (Q5)
Integrated & Returns (Q1) Integrated & Returns (Q5)
Source: Goldman Sachs Global Investment Research. Source: Goldman Sachs Global Investment Research. As of 3/13/2017.
Exhibit 4: Energy and Industrials drove 2016 performance Exhibit 5: Integrated Performance by GICS sector
2016 attribution weighted by GICS Sector; sorted by Q1 vs. Q5 Sorted by 2016
7%
High Integrated Low Integrated GICS Sector 2011* 2012 2013 2014 2015 2016
6% outperformed Low outperformed High
Materials 11% 9% 2% 0% 1% 30%
5%
Energy 9% 37% 8% 34% 21% 18%
4%
Cons Disc. 0% -15% 6% 9% -7% 6%
3%
Info Tech 9% 7% -3% 19% 13% 0%
2%
Cons Staples 1% 27% -29% 0% -7% -1%
1%
Financials 1% 4% -1% -3% -3% -5%
0%
Utilities -10% 5% -4% 2% -8% -12%
-1%
Industrials -11% -3% 7% 14% 18% -14%
Energy Cons Disc Materials Info Tech Cons Utilities Financials Health Industrials
Staples Care Health Care 8% 9% -7% 8% 12% -16%
Q1 Integrated (High Scores) Q5 Integrated (Low Scores)
Note: Telecom and Real Estate have been excluded given small sector size (by # of Sectors with + Alpha 78% 78% 44% 78% 56% 33%
number of names) and limited history, respectively. Note: * 2011 begins on March 28, 2011.
Source: Goldman Sachs Global Investment Research. Source: Goldman Sachs Global Investment Research.
Note: because our factor model is based on GS-defined conviction sectors and not GICS, the number of companies in each
GICS sector will vary by quintile whereas there are equal numbers in Q1/Q5 in our model. Therefore, GICS level attribution
will not add up to overall factor performance. Nonetheless, we find the GICS level aggregation a useful tool in giving
investors a sense as to what sectors are driving overall factor performance.
Quality on Sale?
In our view, factor valuation is a useful gauge of investor sentiment and crowdedness. See
Factor Review and Outlook, The Value Trade, Momentum and Crowding, Jan 4, 2017 for
more details.
With the market trading at near all-time highs, it is not surprising that most factor tails (the
individual Q1s and Q5s) are trading above their historical averages.
However, what is notable is that (1) High Integrated is one of the least expensive factors
(trading at just a 5.5% premium to its 5yr median) while Low Integrated is one of the most
expensive (21.5% premium) when compared against other factors and (2) as a result, the
ratio between the two is at one of the lowest points over the last five years and is the
biggest disconnects of any of the market-neutral factors that we track. See Exhibit 6-7.
Exhibit 6: Integrated is near the cheapest levels since 2012 Exhibit 7: and is more than 2 std deviations below average
Ratio of Forward P/E (Q1 / Q5) Long / Short Factor Valuation
1.0
Forward P/E Current # of St Dev
5yr
Factor (Long/ vs 5yr Above/
Avg.
Short Ratio) Avg. Below Avg.
Ratio of Q1/Q5 Forward P/E
0.8
Size (Large vs. Small) 1.0 0.9 12% 1.4
Source: I/B/E/S, Goldman Sachs Global Investment Research. Source: I/B/E/S, Goldman Sachs Global Investment Research
Exhibit 8: Integrated Q5 (low scores) is trading at a large valuation premium vs. history. The Q1 premium is more modest
Forward P/E Valuation Factors, sorted by difference between current and 5yr median P/E
Current 5-year Median 5-year Range
25 35
30
Forward P/E
15 20 10
High Volatility
Rich Valuation
Performance Laggards (6m)
Low Integrated
Rich EV/FCF
Low Returns
High Returns
Low ROE
Low Short Interest
Low ROCE
Cheap P/B
Cheap P/E
Rich P/E
Rich P/B
Cheap Valuation
High Growth
Large Size
High CROCI
Small Size
Rich EV/EBITDA
Low Dividend Yield
Rich EV/DACF
High Integrated
Cheap EV/DACF
Cheap EV/FCF
Cheap EV/EBITDA
High ROE
High ROCE
High EPS Growth
Low Growth
Low CROCI
One of the reasons for this is the Value input limits the potential to overpay for one of
the other two metrics and therefore is less at risk for a reversal. In addition, we find
Integrated tends to have less macro sensitivity than many of the other factors that we track.
Below we revisit the interplay between our IP factors and macro variables (e.g.
US/European/China Growth, US/Euro FCI, Oil Price and Inflation Expectations) and find that
only about 5% of Integrated performance can be explained by changes in the macro. For
more details see Quantamental Theory: Seasons and Reasons, July 13, 2016.
Exhibit 9: Factor performance and volatility during Exhibit 10: Integrated has the least macro sensitivity
Factormageddon among factors
# of std deviations based on 2 week performance as of 3/8/16 % of performance explained by changes in macro variables
vs. past 5 yrs; factor performance over 2 weeks ending 3/8/16
15% 60%
Factor vs Macro Variable R-squared
At least 35% of
our technical
10% P/B 50% factor perf can be
explained by
macro variables...
Factor Performance (%)
5% 40%
EV/DACF
Valuation
0% 30%
Integrated ...which compares to
Growth just 5% for our
-5% Short Integrated Strategy
P/E Sales Interest Returns 20%
Growth
Leverage CROCI
-10% 10%
ROE
ROCE
-15% Momentum 0%
Volatility
-20%
0 sd 1 sd 2 sd 3 sd 4 sd 5 sd 6 sd 7 sd 8 sd 9 sd
# of Standard Deviations
Source: Goldman Sachs Global Investment Research. Source: Goldman Sachs Global Investment Research.
1
Note this assumes a normal distribution, which is unlikely a realistic assumption for equity prices.
There are numerous academic papers espousing the benefits of factor diversification which typically drive improved
risk-adjusted returns. Much of this benefit stems from the fact that correlations between factors are less than one, and in
some cases, such as Momentum and Value, are negative2.
However, recent industry debate has been around whether a diversified factor approach is best implemented by
combining individual factor portfolios or by combining factors at the single-security level (similar to our Integrated
factor discussed in this report) which has been shown to generate stronger performance with lower volatility than
combining multiple factor strategies.3,4
By comparing Integrated to a simple weighted average of its three constituent factors (Returns, Growth and Value), we
find that the multi-factor approach produces significantly stronger returns since inception (84% vs. 31%) and
consistently outperforms in all but one year (2013). In addition, Integrated produces a better risk-adjusted return (as
gauged by the information ratio) despite the average of Growth, Value and Returns showing lower volatility. This is due
to the dampening effect of the consistently negative correlation between Value and Growth (see Exhibit 12).
Exhibit 11: Integrated has outperformed Fundamental Exhibit 12: and has had stronger performance and
Factors by 53% since inception in 2006 risk-adjusted returns despite slightly higher volatility
Performance of Fundamental Factors vs Integrated Factor Annual. Information Ratio, Perf & Vol Since Inception
1.9
10% Integrated 1.8
+84%
1.8 Growth, Value, Returns Avg
9% 1.6
Performance (Index: Sept 2006)
1.7
8% 1.4
1.6
7%
1.2
1.5
6%
1.4 1.0
5%
1.3 +31% 0.8
4%
1.2 0.6
3%
1.1 0.4
2%
1.0
1% 0.2
0% 0.0
Fundamental Factors (Avg of Returns, Growth, Value) Perf Volatility Information
Integrated Factor (Ann.) (Ann.) Ratio (RHS)
Source: Goldman Sachs Global Investment Research. Source: Goldman Sachs Global Investment Research.
2
Asness, C.S., Moskowitz, T.J. and Pedersen, L.H. (2013), Value and Momentum Everywhere. The Journal of
Finance, 68: 929985. DOI:10.1111/jofi.12021. https://eorder.sheridan.com/3_0/app/orders/4482/files/assets/basic-
html/page-929.html#
3
Bender, Jennifer and Wang, Taie, Can the Whole Be More Than the Sum of the Parts? Bottom-Up versus Top-
Down Multifactor Portfolio Construction. The Journal of Portfolio Management, Vol 42, No. 5 (May 2016).
4
Clarke, Roger G and de Silva, Harindra and Thorley, Steven, Fundamentals of Efficient Factor Investing (October 11,
2016). Financial Analysts Journal, Vol. 72, No. 6 (2016). http://www.cfapubs.org/doi/pdf/10.2469/faj.v72.n6.3
Ticker Company Name Rating Ticker Company Name Rating Ticker Company Name Rating
AB AllianceBernstein Holding Neutral FHB First Hawaiian Inc. Neutral PLD Prologis Inc. Sell
ACC American Campus Communities Inc. Sell FIS Fidelity National Information Services Buy POT Potash Corp. of Saskatchewan Inc. Neutral
ADI Analog Devices Inc. Neutral FLS Flowserve Corp. Neutral PSTG Pure Storage Inc. Neutral
ADM Archer-Daniels-Midland Neutral FMI Foundation Medicine Inc. Neutral PTLA Portola Pharmaceuticals Inc. Neutral
ADSK Autodesk Inc. Buy FNV.TO Franco-Nevada Corp. Neutral RAD Rite Aid Corp. Neutral
ADTN ADTRAN Inc. Sell FSLR First Solar Inc. Neutral RDC Rowan Cos. Neutral
AEM.TO Agnico Eagle Mines Ltd. Neutral FTR Frontier Communications Corp. Neutral RIG Transocean Ltd. Sell
AIV Apartment Investment & Management Neutral GD General Dynamics Corp. Neutral ROLL RBC Bearings Inc. Neutral
ALB Albemarle Corp. Buy* GGP GGP Inc. Neutral ROP Roper Technologies Inc. Neutral
AMC AMC Entertainment Holdings Neutral GHL Greenhill & Co. Sell RSG Republic Services Inc. Neutral
AN AutoNation Inc. Neutral GNC GNC Holdings Sell RSPP RSP Permian Inc. Neutral
APH Amphenol Corp. Buy GNRC Generac Holdings Neutral RUN Sunrun Inc. Buy
APTI Apptio Inc. Neutral GPI Group 1 Automotive Inc. Sell RXN Rexnord Corp. Sell
ARNC Arconic Inc. Sell GPN Global Payments Inc. Buy SAM Boston Beer Co. Neutral
ASNA Ascena Retail Group Neutral GPRO GoPro Inc. Sell SCWX SecureWorks Corp. Buy
ATO Atmos Energy Corp. Neutral H Hyatt Hotels Corp. Neutral SJM J. M. Smucker Co. Sell
AWK American Water Works Neutral HIVE Aerohive Networks Inc. Neutral SLG SL Green Realty Corp. Neutral
BBD__B.TO Bombardier Inc. Neutral HLI Houlihan Lokey Inc. Neutral SQ Square Inc. Buy
BBRY BlackBerry Ltd. Sell HMHC Houghton Mifflin Harcourt Corp. Buy SRCL Stericycle Inc. Neutral
BBT BB&T Corp. Neutral HRI Herc Holdings Neutral SRE Sempra Energy Neutral
BEN Franklin Resources Inc. Sell HSE.TO Husky Energy Inc. Buy SWC Stillwater Mining Co. Neutral
BMS Bemis Co. Neutral HST Host Hotels & Resorts Inc. Sell TAP Molson Coors Brewing Co. Buy
BNFT Benefitfocus Inc. Neutral HUBS HubSpot Inc. Neutral TCS Container Store Group Neutral
BPMC Blueprint Medicines Corp. Buy ICE IntercontinentalExchange Inc. Buy* TEL TE Connectivity Ltd. Sell
BURL Burlington Stores Inc. Buy IMAX IMAX Corp. Neutral TEX Terex Corp. Buy
CCI Crown Castle International Corp. Buy* INFN Infinera Corp. Neutral TIF Tiffany & Co. Neutral
CEQP Crestwood Equity Partners Buy INGR Ingredion Inc. Sell TRI Thomson Reuters Corp. Neutral
CFX Colfax Corp. Neutral IONS Ionis Pharmaceuticals Inc. Sell TRP.TO TransCanada Corp. Buy
CLMT Calumet Specialty Products Partners Neutral IRWD Ironwood Pharmaceuticals Inc. Neutral TRS TriMas Corp. Neutral
CLVS Clovis Oncology Inc. Neutral JACK Jack in the Box Inc. Sell TRUE TrueCar Neutral
CME CME Group Neutral JUNO Juno Therapeutics Inc. Neutral TSLA Tesla Inc. Sell
CRC California Resources Corp. Sell KHC Kraft Heinz Co. Buy* TTOO T2 Biosystems Inc. Neutral
CREE Cree Inc. Sell KLAC KLA-Tencor Corp. Buy TWLO Twilio Neutral
CSLT Castlight Health Inc. Neutral KMI Kinder Morgan Inc. Buy TWOU 2U Inc. Buy
CVE Cenovus Energy Inc. Sell KO Coca-Cola Co. Sell TXMD TherapeuticsMD Inc. Buy
DDR DDR Corp. Neutral LAMR Lamar Advertising Co. Buy TXN Texas Instruments Inc. Sell
DHR Danaher Corp. Neutral LC LendingClub Corp. Neutral UAA Under Armour Inc. Neutral
DISH DISH Network Corp. Buy LGF__A Lions Gate Entertainment Corp. Neutral UFS Domtar Corp. Neutral
DK Delek US Holdings Neutral LL Lumber Liquidators Holdings Sell UNIT Uniti Group Inc. Neutral
DMTX Dimension Therapeutics Neutral LQ La Quinta Holdings Sell UNVR Univar Inc. Buy
DNKN Dunkin' Brands Group Neutral MAC Macerich Co. Neutral URBN Urban Outfitters Inc. Sell
DNR Denbury Resources Inc. Sell MCD McDonald's Corp. Neutral UTX United Technologies Corp. Neutral
DO Diamond Offshore Drilling Sell MCRB Seres Therapeutics Inc. Neutral VSI Vitamin Shoppe Inc. Sell
DVA DaVita Inc. Sell MIK Michaels Cos. Neutral W Wayfair Inc. Neutral
DVN Devon Energy Corp. Neutral MOBL MobileIron Inc. Neutral WAB Wabtec Corp. Neutral
ECL Ecolab Inc. Sell MRVL Marvell Technology Group Neutral WEC WEC Energy Group Neutral
EIGI Endurance International Group Sell MTB M&T Bank Corp. Neutral WEN The Wendy's Co. Neutral
EPC Edgewell Personal Care Neutral MTW Manitowoc Co. Neutral WEX WEX Inc. Neutral
EQGP EQT GP Holdings Neutral MUR Murphy Oil Corp. Sell WFC Wells Fargo & Co. Buy
EQR Equity Residential Sell MYCC ClubCorp Holdings Neutral WFM Whole Foods Market Inc. Sell
EQT EQT Corp. Neutral NAV Navistar International Corp. Neutral WLK Westlake Chemical Corp. Neutral
ERJ Embraer Buy NDAQ Nasdaq Inc. Neutral WM Waste Management Inc. Sell
ES Eversource Energy Neutral NE Noble Corp. Sell WMB Williams Cos. Buy*
ESV Ensco Plc Neutral NI NiSource Inc. Neutral WSTC West Corp. Sell
ETE Energy Transfer Equity Neutral ODP Office Depot Neutral XEC Cimarex Energy Co. Buy
ETN Eaton Corp. Neutral P Pandora Media Inc. Buy* XRAY DENTSPLY Sirona Inc. Neutral
EVER EverBank Financial Corp. Sell PAGP Plains GP Holdings Neutral YUM Yum! Brands Inc. Sell
EVH Evolent Health Inc. Buy* PF Pinnacle Foods Inc. Buy ZEN Zendesk Inc. Buy
FEYE FireEye Inc. Sell PGRE Paramount Group Neutral ZNGA Zynga Inc. Neutral
30%
20% 20%
20%
10% 10%
10%
0% 0% 0%
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
High Low High Low Low High
Growth Growth Returns Returns Multiple Multiple
20% 20%
10%
10% 10%
0% 0% 0%
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5
Low High Large Small Low High
Leverage Leverage Size Size Vol Vol
Returns and Valuation use the Goldman Sachs analyst forecasts at the fiscal year-end at
least three quarters away. Growth uses the value for the fiscal year at least seven
quarters away compared with the year at least three quarters away (on a per-share basis
for all metrics).
These metrics are normalized by assigning a Z-score based on the companys position
within the overall distribution of all IP scores (assuming a normal distribution). The
average of these normalized metrics is taken (or average of the applicable metrics in case
of financials) and is then used to generate a percentile score from 1 to 100 for each factor.
We bucket these company scores into highest quintile (Q1 or top 20%) and lowest
quintiles (20%) within each coverage sector, and construct portfolios with an equal
number of stocks under Q1 and Q5. The performance of these top and bottom quintile
tails, as well as a sector-neutral portfolio (Buy Q1, Sell Q5) of the two, is tracked and
rebalanced on a weekly basis.
Growth: calculated using an average of a companys sales, EBITDA and EPS growth. For
financials, we use only EPS and sales growth. Q1: stocks with the highest sector relative
growth; Q5: stocks with the lowest growth.
Volatility: calculated as the standard deviation of daily total returns over a trailing 12-
month period. Q1: stocks with the lowest volatility on a sector relative basis; Q5: stocks
with the highest volatility.
Balance sheet: calculated using net debt/EBITDA (leverage). This is used only for
nonfinancial stocks. Q1: stocks with the lowest leverage within their sectors; Q5: stocks
with the highest leverage.
Size: calculated using market capitalization. Q1: Largest 20% stocks on a sector relative
basis; Q5: Smallest 20% stocks.
Momentum: based on stock performance over a 6 month lookback period (Q1-Q5). Q1:
Sector leaders (top 20% performers); Q5: Sector laggards (bottom 20%).
Short Interest: based on Short Interest Days (SI / ADTV). Q1: Lowest Days-to-Cover; Q5:
Highest Days-to-Cover. Based on exchange data which is released with a lag.